Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endotype DIrected Treatment for OSA in Down Syndrome

NCT07280468 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT07280468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endotype DIrected Treatment for OSA in Down Syndrome
Lead sponsor
University of Arizona
Phase
Phase 4
Overall status
Recruiting
Start date
March 14, 2026
Completion date
January 31, 2030
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, obstructive sleep apnea (osa)